The Swiss pharmaceutical firm says the acquisition would complement its current pipeline of therapies for neuromuscle problems.
Source link
Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
Related Posts
Asian tech stocks surge as U.S.-Iran cease fire ease Hormuz disruption worries
Xeon server chips proven to CNBC inside Intel’s superior packaging facility in Chandler, Arizona, on November 17, 2025. CNBC Asian…
Memory crisis hits such extremes that ‘even Apple can’t be safe’
Apple CEO Tim Prepare dinner and Jalen Brunson, basketball participant for the New York Knicks, through the first day of…
Microsoft’s new responsible tech lead on high-speed AI development
Absolutely accountable, reliable know-how is an virtually not possible mandate in a tech panorama that prioritizes velocity — however that…